Cognitive Remediation Therapy for Brain Tumor Patients: Improving Working Memory
Completed · Not applicable
Conditions studied: Glioma, Brain Tumor, Primary
In brief
To investigate a computer-based Cognitive Remediation Therapy (CRT) for brain tumor patients at the Massey Cancer Center on measures of cognitive functioning (e.g., working memory, attention, processing speed, language, visuospatial functioning, immediate and delayed memory, or executive functioning) over time.
Key facts
- Study ID
- NCT03323450
- Run by
- Virginia Commonwealth University
- People needed
- 20
- Starts
- 2017-10-20
- Expected to finish
- 2020-06-01
- Last updated by the study team
- 2020-10-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Confirmed primary brain tumor diagnosis via MRI and their neuro-oncologist
- A minimum of 2 months post-surgical resection or biopsy(if applicable)
- and/or a minimum 1 month post radiation treatment (if applicable)
- Karnofsky performance status more than 60
- Estimated intelligence at least 80 (standard score)
- Demonstrated attention difficulties (T-score of at least 65 on attention questionnaire or 1 or more standard deviations below mean on direct attention measures)
- No history of cognitive disorder
- No history of mood disorder
- Predicted life expectancy of at least 12 months
- Computer capability at home or provided a departmental iPad Mini to borrow for study purposes
- Primarily English speaking
- Aged 18+ (for which there is available age-adjusted neuropsychological testing standardization / normative data)
You may not qualify if…
- If they are not patients of Massey Cancer Center or do not meet the inclusion criteria listed above
Where it is running
- Virginia Commonwealth University/Massey Cancer Center — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.